{
  "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
  "docSlug": "560176b410a72a6b2e67af5dd2a20758",
  "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
  "authorId": "neurosense-therapeutics",
  "authorName": "NeuroSense Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 33,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/3",
  "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
  "deckJsonHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56.json",
  "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.044,
        "w": 0.126,
        "x": 0.852,
        "y": 0.028
      },
      "kind": "image",
      "text": "NeuroSense Therapeutics",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4d71ce3-91c4-4471-8da3-1fba27041b1b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.176,
        "w": 0.266,
        "x": 0.36,
        "y": 0.498
      },
      "kind": "list",
      "text": "Significant top line results from Phase 2b study for ALS. Additional catalysts expected: Neurofilament results (Jan 2024), Biomarker results (H1 2024)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1a3eee0b-77b1-4706-8cc6-1535ae64358e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.064,
        "w": 0.266,
        "x": 0.637,
        "y": 0.498
      },
      "kind": "list",
      "text": "Existing partnership with big pharma, and fully funded through Q2 2024",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9cbd2610-7173-410c-b7d9-b42d66d63394",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.096,
        "w": 0.266,
        "x": 0.083,
        "y": 0.498
      },
      "kind": "list",
      "text": "Developing novel therapies for neurodegenerative diseases of high unmet need",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7ccefde-c658-41c9-b592-7b492e059c81",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.46,
        "x": 0.058,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "ALS - Amyotrophic Lateral Sclerosis, also referred to as Lou Gehrig's Disease",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e213ced-aa4d-4137-8e83-d0172b3c5064",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.064,
        "w": 0.484,
        "x": 0.076,
        "y": 0.115
      },
      "kind": "title",
      "text": "NeuroSense Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44b494ef-056e-40e0-a0b3-cb7052c1c5eb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "bfc49666-091a-4d47-99d6-562c82a649ac",
      "evidence": "This slide contains an executive summary of NeuroSense highlights.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}